There is good evidence that B cells can be activated by several distinct pathways. The intensity and isotype of the antibody response of a subset of B cells to certain antigens (Type 2 T-independent antigens) is determined by nonspecific factors produced by T cells and macrophages (1) (2) (3) (4) (5) . A different activation pathway is required for antibody responses to low doses of soluble antigen (6) . This pathway has two cardinal features. First, "classical" inducer T cells must be focused onto target B cells by a foreign protein containing a portion that covalently links the determinant seen by the T inducer and B cells, forming a so-called "antigen bridge." Second, I-A region products on B cells must be the same as those expressed on antigen-presenting cells (APC) 1 that first initiated clonal expansion of the inducer T cell. These observations have given rise to the theory that activated inducer cells bearing receptors for a particular peptide associated with I-A gene products activate B cells that display I-A as well as the peptide antigen bound to the B cell surface immunoglobulin (Ig) receptors. However, there is little direct evidence to support this hypothesis, and no evidence that recognition and activation may be mediated by a secreted form of the inducer cell surface receptor.
In a previous report we described the derivation and the specificity of activation of a panel of hapten-reactive inducer T cell clones. One group of clones, termed conjugate specific, is activated by hapten conjugated to the carrier protein used for in vitro selection and expansion. The second group, termed hapten specific, is activated by a particular hapten coupled to virtually all foreign and autologous proteins. Both types of clones corecognize conventional antigen in association with products of the I-A locus (7) .
In this report, we examine the biologic activity of molecules synthesized and secreted by these hapten-reactive inducer clones. After stimulation by antigen-pulsed adherent cells or the T cell mitogen concanavalin A (Con A), a single inducer clone secretes both antigen-specific inducer peptides as well as nonspecific factors that activate B cells. The latter amplify the response of B cells to Type 2 T-independent antigens and the in vitro response to sheep erythrocytes (SRBC). The former consist of antigen-binding molecules (ABM). ABM induce plaque-forming cell (PFC) responses specific for a determinant recognized by immune B cells, provided that cultures containing ABM and B cells are stimulated with antigen that links the epitope recognized by ABM with the B cell epitope. Induction of B cells by ABM is limited to B cells that express the same I-A allele as the source of the ABM and this H-2-restricted interaction between ABM and B cells reflects binding by ABM to I-A products on B lymphocytes. Finally, analysis of the fine specificity of B cell activation by inducer molecules suggests that inducer T cells can activate B cells by secreting a modified form of their cell-bound receptor.
Materials and Methods
Animals. BALB/c, C57BL/6, C57BL/10, CB6F1, and B10.A(5R) mice were obtained from The Jackson Laboratory, Bar Harbor, ME. B10.A(3R) and B10. Antigens and hnmunizations. Fluoresceinisothiocyanate (FITC), nitrophenyl (NP), and trinitrophenyi (TNP) conjugates were prepared as described (7) . The double conjugates FITC-KLH-TNP or FITC-BGG-TNP were prepared by incubating 50 mg FITC (Sigma Chemical Co., St. Louis, MO) and 40 mg trinitrobenzenesulfonic acid (TNBS) (ICN Nutritional Biochemicals, Cleveland, OH) with 100 mg keyhole limpet hemocyanin (KLH) (Calbiochem-Behring Corp., San Diego, CA) or 100 mg bovine gamma globulin (BGG) in l0 ml of 2% K~COs at room temperature for 2 h, followed by rotation overnight at 4°C and extensive dialysis. Ficoli (mol wt 400,000 Pharmacia, Inc., Piscataway, NJ) and lipopolysaccharide (LPS) (Escherichia coli 0127:B8; Sigma Chemical Co.) were conjugated with E-TNP-L-lysine (ICN Nutritional Biochemicals) as described (8) . TNP conjugated Brucella abortus (B.A.) was prepared as described by Mosier (9) . TNP-conjugated polyacrylamide (PAA) was prepared as previously described (10) . The synthetic polypeptides Lglutamic acid-L-lysine-L-alanine (GLA) and L-glutamic acid-L-lysine-L-tyrosine (GLT) were a generous gift of Dr. M. Dorf, Harvard Medical School.
Mice were primed to TNP-KLH, NP-KLH, or TNP-Bovine serum albumin (BSA) by i.p. immunization with 200 ~g antigen in complete Freund's adjuvant. In some cases mice were boosted with 100 #g antigen in saline 6-10 wk later. Mice were used 4-8 wk after the last immunization.
Lyt + T Cell Clones. The derivation and maintenance of the hapten-specific T cell clones was described in the preceding paper (7).
• Media. Cells were cultured in Dulbecco's modified Eagle's Medium (DME) (Gibco Laboratories) supplemented with essential and nonessential amino acids, essential vitamins, 10% fetal calf serum, 1 mM sodium pyruvate, 2 mM L-glutamine, and 5 × 10 -5 M 2-mercaptoethanol (complete medium).
Preparation of Supernatants. Pulsed adherent cells (PAC) were prepared by incubating 5 x 106 irradiated (2,000R) spleen cells syngeneic with the clone with 100 ~g/ml antigen in 24-well tissue culture plates (Linbro, # 76-033-05, Flow Laboratories, McLean, VA).
After 2 h, the wells were washed with phosphate-buffered saline (PBS) to remove nonadherent cells (>98% of the cell population) and excess antigen. 106 CI.Lyl-T1 or CI.Lyl-N5 were then added. After 24 h, the supernatants were removed, spun at 1,200 rpm and stored at -20°C. In some cases, supernatants were incubated with TNP-BGG Sepharose, FITC-BGG Sepharose, or NP-OVA Sepharose (0.5 ml Sepharose/ml supernatant) for 2 h at 4°C. After washing, columns were eluted with 0.1 M ammonium hydroxide and neutralized with 0.5 M sodium phosphate. The eluate was then applied to a PD 10 column (Pharmacia) and eluted with complete medium. In some cases, supernatants were prepared by incubating 106 CI.Lyt-T1 or CI.Lyl-N5 with 1 ug Con A in 1 ml complete medium. Supernatants were harvested after 24 h and 10 mg]ml a-methylmannoside was added. Supernatants were fractionated as described above.
B Cell Culture. B plus accessory cells were prepared by sequential positive and negative selection. After elution t?om rabbit anti-mouse Fab-coated plates (11) , cells were incubated with monoclonal (mc) anti-Thy-l.2, anti-Lyl.2, and anti-Ly2.2 plus rabbit complement for 45 min at 37°C and washed with PBS. Lack of residual T cells was verified by immunofluorescence using anti-Thy-1 antibody, as well as by the loss of proliferative response to Con A and the anti-SRBC piaque-forming cells (PFC) response in vitro. No attempts were made. to deplete macrophages from these populations. Accessory cells are still present as judged by the reconstitution of a primary anti-SRBC response with positively selected Lyl ÷ T cells.
3 x 106 (B plus accessory cells) were incubated in complete medium (1 ml volumes in 24-well (Linbro) plates) at 37 °C in 10% CO2, and supplemented daily with 0.1 ml medium. PFC were enumerated on day 4. Antigen was added at the following concentration: 0.1 #g/ml hapten-protein antigens, 0.05 ml of a 10% TNP-PAA solution, 0.01 #g/mi TNPficoll or 5 x 106 SRBC/ml. In some cases, cultures were supplemented with adherent cells (macrophages) as described above. PFC Assa~,. PFC were determined by the Jerne plaque technique as modified by Dresser anc[ Greaves (12) . TNP-SRBC were prepared as described by Rittenberg and Pratt (13) . NP-SRBC were prepared as described by Sherr et al (14) . FITC-SRBC were prepared as described by Ramos and Moiler (15) . Anti-SRBC PFC were assayed on SRBC. In some cases rabbit anti-mouse Ig (Cappel Laboratories, Cochranville, PA) was used to develop IgG PFC. All PFC results represent the mean of duplicate or triplicate cultures; in all cases the standard error was <10%.
Incubation of Inducer Molecules with
The distribution of affinity of the antibody response was determined by the PFC inhibition procedure of Andersson (16) . E-TNP-L-iysine (ICN Pharmaceuticals, Cleveland, OH) or NP-caproate (Biosearch, San Rafael, CA) was used to inhibit anti-TNP and anti-NP plaques, respectively and was added to both the agarose and the complement where indicated. Unless otherwise indicated the number of PFC per culture represent only those plaques that were inhibited with 10-'~M TNP-lysine or NP-caproate.
Results

Demonstration of Antigen-specific Inducer Activity by a TNP-spec~c T Cell Clone
We have generated a series of hapten-specific, Thyl +, Lyl+2-3 -T cell clones. CI.Lyl-N5 is activated only by NP-OVA associated with I-A b gene products; CI.Lyl-T1 is activated by TNP coupled to virtually any protein associated with I-A d APC (7).
We asked whether the TNP-specific clone CI.Lyl-T1 might induce purified (B plus accessory cells) from mice immune to FITC to secrete anti-FITC antibody. Cultures containing CI.Lyl-T1, B cells from donors immune to FITC-BGG, and the double conjugate FITC-KLH-TNP produced strong anti-FITC PFC responses ( Fig. 1 ). Cultures containing a mixture of FITC-KLH and TNP-KLH did not produce significant responses even when the concentration of each conjugate was 10-100-fold higher than FITC-KLH-TNP (not shown). Thus, CI.Lyl-T1 induces B cells to secrete anti-hapten antibody to hapten-protein antigens only if the determinant recognized by the clone (i.e., TNP) is covatently coupled to the determinant recognized by immune B cells.
C1. Lyl-T1 and CI.Lyl-N5 Synthesize Molecules that Mediate Specific Inducer Function
To obtain molecules that mediate the activity of the intact inducer clone, supernatants were prepared by incubating CI.Lyl-T1 with either (a) syngeneic antigen-pulsed APC or (b) Con A in the absence of other cells. These supernatants were applied to hapten-coupled Sepharose 4B columns. The eluate from a TNPSepharose column was tested for induction of anti-FITC PFC responses using the assay described above. The eluate induced anti-FITC PFC responses in cultures containing the double conjugate FITC-BGG-TNP but not in cultures containing FITCoBGG + TNP-BGG (Fig. 1) . The effluent contained no activity. Thus, both the inducer clone as well as products synthesized by the clone activate B cells via an antigen bridge.
We next examined the ability of hapten-reactive inducer cells or their products to activate (B plus accessory cells) to produce antibody to the same hapten. FIGURE 2. Secreted ABM binds specifically to hapten. 3 x 106 purified B cells from NP-KLH-primed C57BL/6 mice were incubated with 0.1 /~g/ml NP-OVA. Supernatant from CI.LyI-N5 was fractionated on the indicated column and 0.| ml o£ the eluate or effluent was added to the culture. Supernatants of the NP-specific clone CI.Lyl-N5 prepared as described above were applied to Sepharose columns coupled with NP or FITC. The eluate and effluent fractions were tested for induction of antibody production by B cells primed to NP-KLH. The eluate from the NP-Sepharose column induced anti-NP PFC responses (Fig. 2) ; the effluent (representing "-'95-98% of internally labeled protein (data not shown)) did not. The eluate from the NP-coupled column contained molecules specifically bound to NP but not to another hapten: the effluent but not the eluate from a FITC-coupled column induced an anti-NP PFC response 2 (Fig. 2 ). These findings demonstrate that (a) hapten-or antigen-binding molecules (ABM) can induce B cells to produce antibody to the same hapten, and (b) since ABM bind to Sepharose coupled with the appropriate hapten, NP, but not an inappropriate hapten (FITC), ABM mediate at least part of the B cell induction. Additionally, a dose-response curve of inducer activity in supernatants of both clones showed that (a) substantial inducer activity was demonstrable even at dilutions of 1:1,000 (the equivalent of 104 cloned cells) and (b) the activity present in the unfractionated supernatant was completely recovered in the eluate (Table I) . Although only IgM PFC were detected in these assays, in all cases 75-80% of the anti-TNP PFC were inhibitable with 10 -5 M TNP-lysine. In contrast, the small numbers of anti-TNP or NP PFC produced in cultures in the absence of inducer cells or ABM were not inhibited with 10 -5 M TNP-lysine or NP-caproic acid.
To determine whether ABM are shed or secreted by the clone, the supernatant from C1.Lyl-N5 was applied to and eluted from an NP-coupled column and was centrifuged for 60 min at 100,000 g. This procedure did not decrease inducer activity in the eluate (Fig. 2) , suggesting that inducer activity is mediated by secreted ABM rather than mediated by fragments of cell membranes or liposomes.
Evidence that ABM Represent a Secreted Form of the Cell Surface Receptor
H-2 restriction of specific inducer activity by ABM. To determine whether inducer activity mediated by ABM is restricted to B cells/macrophages sharing the same H-2 genes, the eluate fraction of supernatant from clone C1.Lyl-T1 (H-2 d) was added to cultures containing purified (B plus accessory cells) from either TNP-KLH-primed BALB/c or C57BL/6 mice and irradiated CB6FI adherent cells from unprimed mice. The eluate induced BALB/c but not C57BL/6 B cells to produce strong anti-TNP PFC responses (Fig. 3) .
To map this restriction more precisely, the eluate prepared from clone C1.Lyl-N5(H-2 b) was added to purified (B plus accessory cells) from NP-KLH-primed B10 (H-2 b) or B10.A (4R) (H-2 h4) mice, which differ only at the H-2K and I-A loci. A substantial anti-NP response was induced in cultures containing B10 but not B10.A (4R) (B plus accessory) cells.
The above experiments show that anti-hapten responses to hapten-protein conjugates were obtained only when inducer ABM were incubated with B cells (and possibly macrophages) identical at the I-A locus (Fig. 3) . One explanation for this observation is that the secreted ABM represents a modified form of the cell-bound receptor and, like the inducer ceil, recognizes I-A gene products in association with antigen. To directly test this hypothesis, ABM were incubated with syngeneic or ailogeneic B cells and then assayed for antigen-specific inducer activity. Incubation with activated B cells from allogeneic strains had no effect on subsequent inducer activity; in contrast, incubation with strains identical at the I-A region (e.g., B6 vs. B10A.4R) resulted in the complete loss of inducer activity (Table II) . In experiments not shown we found that ABM inducer activity was also depleted after incubation with unactivated syngeneic, but not allogeneic 
TABLE II
Loss of Inducer Activity Following Preincubation of ABM with Syngeneic Activated B Cells
Source B cells. However, removal of inducer activity was incomplete, implying that activated B cells express more surface I-A than do resting B cells. This result does not bear on whether the secreted ABM is composed of two separate proteins that bind to antigen and to I-A, respectively, or one that binds both. However, collectively these experiments show that activation of B cells is mediated by secreted inducer molecules that recognize both antigen and I-A products on B cells.
Fine specificity of B cell activation by ABM. CI.Lyl-T1 is activated by autologous or foreign proteins such as the synthetic polymer TNP-GLA that are restricted by I-A d gene products (e.g. TNP-GLA). In contrast, TNP coupled to I-E controlled polymers (such as GLT) (25) does not activate C1.Lyl-T1 (7). We reasoned that if ABM secreted by CI.Lyl-T1 represents a secreted form of the receptor, then ABM might display the same fine specificity as the receptor. Failure of ABM to recognize and bind to TNP-GLT/I-A complexes on B cells might prevent delivery of the inducer signal to the target B cell. This was the case (Fig. 4) : incubation of TNP-primed B cells with ABM and TNP-GLA but not TNP-GLT elicited strong anti-TNP responses. These findings show that secreted inducer molecule(s) that activate PFC responses co-recognize I-A and antigen on B cells with the same fine specificity as the cell-bound receptor. The most parsimonious interpretation of these observations is that ABM represents a secreted product of the same gene(s) that encode the T cell receptor.
Separation of Antigen-specific from Nonspecific Helper Factors
Although antigen-specific B cell activation by CI.Lyl-T1 and C1.Lyl-N5 is mediated by molecules that co-recognize antigen and I-A displayed on B cells (Figs. 2-4) , these clones also produce factors that induce B cell responses independent of an antigen bridge (nonspecific help). We attempted to separate the inducer cell products responsible for the two functions. Supernatants from antigen-stimulated CI.Ly 1-T 1 were applied to TNP-coupled Sepharose columns. The eluate, effluent, and unfractionated supernatant were tested for nonspecific and specific inducer activity (Fig. 5) . Unfractionated supernatant as well as the eluate from the TNP-Sepharose column stimulated the production of antioTNP PFC by B cells from mice immune to TNP-KLH while the effluent did not induce a significant anti-TNP PFC response at any concentration tested. Moreover, neither the whole supernatant nor the TNP-column eluate induced B cells from mice primed to FITC-KLH to respond to FITC-BGG, confirming and extending earlier results indicating the specificity of B cell activation by ABM (Figs. 2 and 3) .
These data also show that the unfractionated supernatant induces virgin B cells to generate anti-SRBC PFC. However, in contrast to induction of hapten- specific PFC responses, the inducer activity resided in the column effluent. Thus, a single helper cell produces both antigen-specific and nonspecific inducer molecules; the two can be separated on Sepharose columns coupled with the appropriate antigen.
Clone Supernatants Enhance B Cell Responses to Type 2 T-independent Antigens
Responses to the Type 1 T-independent antigens TNP-lipopolysaccharide (TNP-LPS) and TNP-Brucella abortus (TNP-BA) appear to be independent of T cells. However, recent studies have shown that responses to the Type 2 Tindependent antigens TNP-polyacrylamide (TNP-PAA) and TNP-ficoll are in fact dependent on T cells or their products (1, 2). We therefore asked whether CI.Lyl-T1 or C1.Lyl-N5 inducer cell products might induce B cells to respond to Type 1 or 2 T-independent antigens. Purified B cells (and macrophages) from unprimed mice were incubated with different T-independent antigens (Table  I I I) . Addition of unfractionated clone supernatant greatly increased the response to TNP-PAA and TNP-ficoll (Type 2 antigens), but had no effect on the response to TNP-LPS or TNP-BA (Type I antigens). Induction was due to nonspecific factors rather than to TNP-specific ARM because (a) whole supernatants enhanced the response to FITC-PAA (Table III) clones also synthesize and secrete factors that bind to antigen (ABM) and activate only those B cells that are (a) linked to the antigen via a bridge and (b) syngeneic with the inducer clone at I-A (H-2 restriction). We show that this phenomenon, "antigen-specific, H-2-restricted" help, reflects binding of ABM to both I-A and antigen on the B cell surface. These studies explain, in part, the failure despite extensive effort to identify inducer molecules that mediate the activity of the intact ceil. There are several reasons for this. First, considerably higher concentrations of antigen-specific peptides may be synthesized by homogeneous populations (clones) of T cells than by heterogeneous populations or by T cells that have been fused with tumors. Second, both antigen-specific and nonspecific factors are synthesized solely by the T cell clones because both are produced after activation either by antigenpulsed APC or by Con A in the absence of other cell types. It is essential to separate nonspecific helper factors from ABM on antigen-coupled columns before assay because antigen-specific inducer activity is normally masked by the nonspecific factors produced after clonal activation.
Previous studies demonstrated that supernatants from T cell hybridomas can augment in vitro PFC responses of cultures containing both T and B cells (17, 18) . This augmenting activity is lost after passage of supernatants through columns conjugated with (a) anti-I-A (17, 18), (b) antiidiotype (17) , (c) anti-VH (17, 18) , and (d) antigen (17, 18) . In all cases biologic activity was measured by PFC generated from spleen cells rather than purified B cells: the augmenting activity of these factors may reflect an effect on T cells rather than a direct effect on B cells. There is a single report suggesting that factors from T cell clones specific for horse erythrocytes bind specifically to erythrocytes and "prepare" small B cells to make antibody after a second encounter with B cell replication and maturation factors (19) . However, this study and others show that activated Lyl + T cells produce nonspecific lymphokines that are sufficient to stimulate division and production of anti-SRBC PFC by cultures containing purified B cells and macrophages (3) (4) (5) .
ABM present in the eluate from hapten-coupled Sepharose columns induce anti-hapten PFC responses to hapten-protein conjugates but do not activate responses to SRBC or Type 2 antigens. B cell growth factors have been shown to be required for the latter responses (1) (2) (3) (4) (5) and may well be involved in the former. Perhaps enough of this material is complexed with the ABM and is efficiently targeted to the appropriate B cell. Preliminary results show that some BCGF activity is present in column eluates but at much lower concentrations than in the effluent (data not shown).
The concept ofa hapten-specific helper T cell is relatively recent. The majority of T cells recognize protein carriers, whereas B cells can produce antibody to either hapten or protein determinants. The findings reported here emphasize that there is no functional division of labor based on specificity for protein and haptenic determinants. This is most directly shown by our demonstration that a hapten can "help" itself. Previous failures to demonstrate hapten-specific help probably reflect the predominance of inducer clones that recognize hapten only in association with a unique amino acid sequence on the carrier protein (7) .
Hapten-specific helper activity mediated by ABM is H-2 restricted since (a) help is restricted to B cells that share I-A identity and (b) help can be depleted by incubation of inducer ABM on syngeneic but not allogeneic activated B cells. It is therefore of interest that ABM activity is retained on hapten-coupled Sepharose columns that lack I-A. Possibly, multiple epitopes stabilized on a solid surface provide a sufficient matrix for low affinity binding in the absence of MHC products. Alternatively, it is possible that MHC products are carried over from the cell culture.
We used the double hapten conjugate FITC-KLH-TNP to show that significant antibody responses require targeting of the cloned cells (C1.Lyl-T1) or its product(s) to the B cell by an antigen bridge, despite the fact that IgM and not IgG PFC were induced. Roehm et al. (20) , who measured only IgM PFC, also demonstrated a requirement for linked recognition in cultures containing low doses of antigen and an antigen-specific T cell hybridoma. This is in contrast to the findings of Asano et al. (6) . Their results suggest that Lyb5-B cells require linked recognition as well as H-2 identity between B cells, T cells, and macrophages to produce IgG. In contrast, Lyb5 + B cells produce IgM in the absence of an antigen bridge, although high doses of antigen are required.
The above data may be reconciled if B cells (e.g. Lyb5-) that require linked recognition and MHC identity fail to switch to IgG production in the absence of factors provided by a second T cell. Limiting dilution studies of Rosenberg and Asofsky (21) suggest that while one type of helper cell is sufficient for an IgM PFC response in vitro, two are needed for an IgG response (21). Isakson et al. (22) have shown that some T cell lines or hybridomas produce factors that are capable of mediating an IgM to IgG transition in vitro (22) . We have isolated a clone that is reactive to autologous I-A on activated B cells (Clayberger, C., R. H. DeKruyff, and H. Cantor, manuscript submitted). The cell, or its products, stimulate an IgM to IgG switch in the in vitro system described here as well as in other in vivo and in vitro systems. For example, addition of this clone or its products to cultures containing ABM and hapten-primed B cells results in a strong IgG response. This type of cell may be particularly important in the response to antigens containing repeating epitopes (e.g. highly conjugated TNP-BGG) to which an IgG response is not as readily obtained (23) .
After activation, CI.Lyl-T1 and C1.Lyl-N5 also produce antigen nonspecific, H-2-restricted factors that promote B cell responses to SRBC or Type 2 Tindependent antigens. Responses to both antigens depend on factors from activated T cells and/or macrophages, which may include interleukin 1, interleukin 2, and B cell growth factors (5) . Addition of factors from activated macrophages alone had no effect on the anti-SRBC or Type 2 responses studied here (data not shown), presumably because preparations contained sufficient numbers of macrophages; all nonmacrophage factors necessary for activation of these PFC responses were provided by T cell clones.
The finding that ABM inducer activity in the supernatant is not diminished after ultracentrifugation (100,000 g for 1 h) suggests that ABM are secreted products of inducer cells. In principle cytoplasmic proteins released from dead cells may remain in the supernatant after centrifugation. However, ABM activitry is highest early after activation of the clones (24) , when cell viability is highest (>95%). Experiments to demonstrate that ABM are secreted, rather than shed or released, are currently in progress.
The data reported here thus strongly support the view that ABM represent a modified, secreted form of the cell surface receptor. If the fine specificity of activation of CI.Lyl-T1 is determined by a cell-bound receptor, then this recognition structure has the following three properties: (a) it distinguishes completely between TNP and FITC, (b) it recognizes a portion of the I-A gene product, and (c) it does not recognize TNP conjugated to I-E-controlled polymers such as GLT (25) , but responds well to TNP coupled to I-A-controlled polymers such as GLA. The specificity of ABM activation of B cells displays these features: (a) ABM binds to TNP-Sepharose and not FITC-Sepharose columns. (b) inducer activity is lost after incubation with B cells expressing the I-A genotype identical to that of the clone, and (c) ABM from CI.Lyl-T1 activates B cells cultured with TNP-GLA but fails to stimulate B cells cultured with TNP-GLT. Thus, ABM are characterized by properties analogous to those displayed by the cell-bound receptor and most likely represent a modified form of this structure.
Taken together, these findings indicate that at least some antibody responses to proteins may not depend on cognate B cell-T cell interaction. Instead, a secreted form of the inducer T cell receptor induces antibody secretion by antigen-specific, I-A identical B cells. The fine specificity of secreted inducer molecules, as defined here, ensures that B cell clones activated by secreted ABM belong to the same pool as those triggered by the intact inducer cell.
Summary
The biologic activity of molecules synthesized and secreted by hapten-specific inducer T cells was examined. After activation, a single inducer clone secretes both antigen-specific inducer peptides as well as nonspecific factors. The nonspe- 
